|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,060.50 INR | -0.89% |
|
+0.01% | -6.19% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Pharmaceutical Products | |||||||
Pharmaceuticals | 6.22TCr | 7.78TCr | 8.75TCr | 10TCr | 12TCr | ||
Total Assets | 6.37TCr | 9.15TCr | 9.72TCr | 12TCr | 28TCr | ||
Interest Expense | -19Cr | -56Cr | -40Cr | -29Cr | -420.89Cr | ||
Income Tax Expense | 398.58Cr | 521.64Cr | 361.56Cr | 457.59Cr | 509.74Cr | ||
CAPEX | -308.43Cr | -464.86Cr | -789.02Cr | -315.33Cr | -460.79Cr | ||
EBT | 1.69TCr | 1.96TCr | 1.66TCr | 2.38TCr | 2.5TCr | ||
D&A | 115.44Cr | 161.64Cr | 320.81Cr | 389.52Cr | 594Cr | ||
Net Income | 1.27TCr | 1.43TCr | 1.28TCr | 1.91TCr | 1.99TCr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
India | 6.03TCr | 7.59TCr | 8.45TCr | 9.52TCr | 11TCr | ||
Total Assets | 6.06TCr | 4.35TCr | 4.84TCr | 4.86TCr | 20TCr | ||
Outside India | 185.9Cr | 186.81Cr | 295.83Cr | 813.46Cr | 1.53TCr | ||
Total Assets | 313.59Cr | 11Cr | 30Cr | 33Cr | 221.62Cr | ||
Unallocated | 9.47Cr | - | - | - | - |
- Stock Market
- Equities
- MANKIND Stock
- Financials Mankind Pharma Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition